The sufficiency of disclosure of medical artificial intelligence patents
![Untitled design6](https://europeantech.news/wp-content/uploads/2024/03/Untitled-design6-500x470.png)
US FDA. Artificial intelligence and machine learning (AI/ML)-enabled medical devices. https://www.fda.gov/medical-devices/software-medical-device-samd/artificial-intelligence-and-machine-learning-aiml-enabled-medical-devices (2023)
Aboy, M., Price, W. N. II & Raker, S. Nat. Biotechnol. 41, 461–468 (2023).
Ebrahim, T. Y. Penn State L. Rev. 125, 147–221 (2020).
Ouellette, L. L. Harv. J. L. Technol. 25, 545–607 (2011).
World Intellectual Property Organization. Certain aspects of national/regional patent laws: sufficiency of disclosure. https://www.wipo.int/export/sites/www/scp/en/national_laws/disclosure.pdf (2023).
Braga, E. J. et al. World Pat. Inf. 53, 58–65 (2018).
Lemley, M. A. Wis. L. Rev. 2013, 905–964 (2013).
Ferrero Guillén, R. & Breckwoldt Jurado, A. Digit. Soc. 2, 3 (2023).
Price, N. Cardozo Law Rev. 37, 1401–1453 (2017).
Robinson, W. K. Houst. Law Rev. 60, 331–362 (2022).
Bubela, T. et al. Nat. Biotechnol. 31, 202–206 (2013).
Smith, J. A. et al. Nat. Biotechnol. 36, 1043––1047 (2018).
Aboy, M., Minssen, T. & Kop, M. Int. Rev. Intellect. Prop. Compet. Law 53, 853–882 (2022).
Aboy, M., Liddell, K., Liddicoat, J. & Crespo, C. Nat. Biotechnol. 34, 1119–1123 (2016).
Aboy, M., Liddicoat, J., Liddell, K., Jordan, M. & Crespo, C. Nat. Biotechnol. 35, 820–825 (2017).
Aboy, M., Liddell, K., Jordan, M., Crespo, C. & Liddicoat, J. Nat. Biotechnol. 40, 465–471 (2022).
Aboy, M., Crespo, C., Liddell, K., Minssen, T. & Liddicoat, J. Nat. Biotechnol. 37, 513–518 (2019).
Price, W., Nicholson, I. & Rai, A. K. Iowa Law Rev. 106, 775–812 (2020).
Price, W. N. II & Rai, A. K. Nat. Biotechnol. 37, 862–863 (2019).